Literature DB >> 26599172

Cancer Immunotherapy Researchers Focus on Refining Checkpoint Blockade Therapies.

Julie A Jacob.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26599172     DOI: 10.1001/jama.2015.10795

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer.

Authors:  Xin Jin; Zhaorui Liu; Dongxiao Yang; Kai Yin; Xusheng Chang
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

2.  Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors.

Authors:  Jeremy M O'Connor; Kathi Seidl-Rathkopf; Aracelis Z Torres; Paul You; Kenneth R Carson; Joseph S Ross; Cary P Gross
Journal:  Oncologist       Date:  2018-07-16

Review 3.  Influence of microbiota on immunity and immunotherapy for gastric and esophageal cancers.

Authors:  Xiaoli Zhang; Zui Pan
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-06-04

4.  Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200.

Authors:  Daruka Mahadevan; Mark C Lanasa; Charles Farber; Manjari Pandey; Maria Whelden; Susan J Faas; Terrie Ulery; Anjli Kukreja; Lan Li; Camille L Bedrosian; Xiaoping Zhang; Leonard T Heffner
Journal:  J Immunother Cancer       Date:  2019-08-23       Impact factor: 13.751

Review 5.  Use of immunotherapy in the treatment of gastric cancer.

Authors:  Luhong Yang; Yanxia Wang; Huafeng Wang
Journal:  Oncol Lett       Date:  2019-09-30       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.